Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
Funding Amount
Not stated
Deadline
February 6, 2029
853 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Special district governments
- Tribal governments
- Tribal organizations
- State governments
- School districts
- County governments
- Nonprofits (501(c)(3))
- Private colleges & universities
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
Overview
NIGMS intends to continue its flagship Maximizing Investigators' Research Awards (MIRA) program for Early Stage Investigators (ESIs). Over the past decade, MIRA has become the primary approach through which NIGMS supports fundamental, investigator-initiated research. MIRA provides support for research in an investigator's laboratory that falls within the mission of NIGMS through a single grant award. It provides investigators with greater funding stability and scientific flexibility, enabling researchers to take on more ambitious and innovative studies, enhancing scientific productivity and the chances for important breakthroughs. It also reduces administrative burden by combining all NIGMS research support for a PI into a single award. The program is structured to distribute funds widely among the nation's highly talented and promising early career investigators.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: PAR-26-032
- Instrument: grant
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI). Now let's win it.